Significance of immunohistochemical expression of estrogen receptors α and β in squamous cell carcinoma of the esophagus

Tadahiro Nozoe, Tsunehiro Oyama, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Purpose: Possible significance of sex hormone estrogen as an antitumor therapeutic arm toward esophageal squamous cell carcinoma (ESCC) cells has been suggested. The aim of the current study was to clarify the clinicopathologic significance of an immunohistochemical expression of estrogen receptors α and β (ERα and ERβ) in ESCC. Experimental Design: Expression of ERα and ERβ were examined using an immunohistochemical methods in 73 paraffin-embedded sections collected from patients with ESCC who had been subjected to esophageal resection and digestive reconstruction without any preoperative induction therapy. Results: Forty-seven (64.4%) ESCCs had a positive cytoplasmic expression of ERα and 21 (28.8%) ESCCs had a positive nuclear expression of ERβ. Univariate analysis showed that both positive ERα expression (P = 0.0001) and negative ERβ expression (P = 0.026) were unfavorable prognostic indicators in ESCC. Moreover, multivariate analysis showed that ERα-positive/ERβ-negative expression (P = 0.003) and progression of tumor stage (P = 0.014) were found to be independent unfavorable prognostic indicators in ESCCs. Conclusions: Immunohistochemical expression of ERα and ERβ were found to be observed in ESCC. Positive expression of ERα in addition to negative expression of ERβ proved to be an unfavorable independent prognostic indicator in ESCC.

Original languageEnglish
Pages (from-to)4046-4050
Number of pages5
JournalClinical Cancer Research
Volume13
Issue number14
DOIs
Publication statusPublished - Jul 15 2007

Fingerprint

Estrogen Receptors
Esophagus
Squamous Cell Carcinoma
Gonadal Steroid Hormones
Paraffin
Esophageal Squamous Cell Carcinoma
Estrogens
Research Design
Multivariate Analysis
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Significance of immunohistochemical expression of estrogen receptors α and β in squamous cell carcinoma of the esophagus. / Nozoe, Tadahiro; Oyama, Tsunehiro; Takenoyama, Mitsuhiro; Hanagiri, Takeshi; Sugio, Kenji; Yasumoto, Kosei.

In: Clinical Cancer Research, Vol. 13, No. 14, 15.07.2007, p. 4046-4050.

Research output: Contribution to journalArticle

Nozoe, Tadahiro ; Oyama, Tsunehiro ; Takenoyama, Mitsuhiro ; Hanagiri, Takeshi ; Sugio, Kenji ; Yasumoto, Kosei. / Significance of immunohistochemical expression of estrogen receptors α and β in squamous cell carcinoma of the esophagus. In: Clinical Cancer Research. 2007 ; Vol. 13, No. 14. pp. 4046-4050.
@article{2ec43ccf14cb49f0b21084b9fd254d68,
title = "Significance of immunohistochemical expression of estrogen receptors α and β in squamous cell carcinoma of the esophagus",
abstract = "Purpose: Possible significance of sex hormone estrogen as an antitumor therapeutic arm toward esophageal squamous cell carcinoma (ESCC) cells has been suggested. The aim of the current study was to clarify the clinicopathologic significance of an immunohistochemical expression of estrogen receptors α and β (ERα and ERβ) in ESCC. Experimental Design: Expression of ERα and ERβ were examined using an immunohistochemical methods in 73 paraffin-embedded sections collected from patients with ESCC who had been subjected to esophageal resection and digestive reconstruction without any preoperative induction therapy. Results: Forty-seven (64.4{\%}) ESCCs had a positive cytoplasmic expression of ERα and 21 (28.8{\%}) ESCCs had a positive nuclear expression of ERβ. Univariate analysis showed that both positive ERα expression (P = 0.0001) and negative ERβ expression (P = 0.026) were unfavorable prognostic indicators in ESCC. Moreover, multivariate analysis showed that ERα-positive/ERβ-negative expression (P = 0.003) and progression of tumor stage (P = 0.014) were found to be independent unfavorable prognostic indicators in ESCCs. Conclusions: Immunohistochemical expression of ERα and ERβ were found to be observed in ESCC. Positive expression of ERα in addition to negative expression of ERβ proved to be an unfavorable independent prognostic indicator in ESCC.",
author = "Tadahiro Nozoe and Tsunehiro Oyama and Mitsuhiro Takenoyama and Takeshi Hanagiri and Kenji Sugio and Kosei Yasumoto",
year = "2007",
month = "7",
day = "15",
doi = "10.1158/1078-0432.CCR-07-0449",
language = "English",
volume = "13",
pages = "4046--4050",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Significance of immunohistochemical expression of estrogen receptors α and β in squamous cell carcinoma of the esophagus

AU - Nozoe, Tadahiro

AU - Oyama, Tsunehiro

AU - Takenoyama, Mitsuhiro

AU - Hanagiri, Takeshi

AU - Sugio, Kenji

AU - Yasumoto, Kosei

PY - 2007/7/15

Y1 - 2007/7/15

N2 - Purpose: Possible significance of sex hormone estrogen as an antitumor therapeutic arm toward esophageal squamous cell carcinoma (ESCC) cells has been suggested. The aim of the current study was to clarify the clinicopathologic significance of an immunohistochemical expression of estrogen receptors α and β (ERα and ERβ) in ESCC. Experimental Design: Expression of ERα and ERβ were examined using an immunohistochemical methods in 73 paraffin-embedded sections collected from patients with ESCC who had been subjected to esophageal resection and digestive reconstruction without any preoperative induction therapy. Results: Forty-seven (64.4%) ESCCs had a positive cytoplasmic expression of ERα and 21 (28.8%) ESCCs had a positive nuclear expression of ERβ. Univariate analysis showed that both positive ERα expression (P = 0.0001) and negative ERβ expression (P = 0.026) were unfavorable prognostic indicators in ESCC. Moreover, multivariate analysis showed that ERα-positive/ERβ-negative expression (P = 0.003) and progression of tumor stage (P = 0.014) were found to be independent unfavorable prognostic indicators in ESCCs. Conclusions: Immunohistochemical expression of ERα and ERβ were found to be observed in ESCC. Positive expression of ERα in addition to negative expression of ERβ proved to be an unfavorable independent prognostic indicator in ESCC.

AB - Purpose: Possible significance of sex hormone estrogen as an antitumor therapeutic arm toward esophageal squamous cell carcinoma (ESCC) cells has been suggested. The aim of the current study was to clarify the clinicopathologic significance of an immunohistochemical expression of estrogen receptors α and β (ERα and ERβ) in ESCC. Experimental Design: Expression of ERα and ERβ were examined using an immunohistochemical methods in 73 paraffin-embedded sections collected from patients with ESCC who had been subjected to esophageal resection and digestive reconstruction without any preoperative induction therapy. Results: Forty-seven (64.4%) ESCCs had a positive cytoplasmic expression of ERα and 21 (28.8%) ESCCs had a positive nuclear expression of ERβ. Univariate analysis showed that both positive ERα expression (P = 0.0001) and negative ERβ expression (P = 0.026) were unfavorable prognostic indicators in ESCC. Moreover, multivariate analysis showed that ERα-positive/ERβ-negative expression (P = 0.003) and progression of tumor stage (P = 0.014) were found to be independent unfavorable prognostic indicators in ESCCs. Conclusions: Immunohistochemical expression of ERα and ERβ were found to be observed in ESCC. Positive expression of ERα in addition to negative expression of ERβ proved to be an unfavorable independent prognostic indicator in ESCC.

UR - http://www.scopus.com/inward/record.url?scp=34547103740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547103740&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-07-0449

DO - 10.1158/1078-0432.CCR-07-0449

M3 - Article

C2 - 17634528

AN - SCOPUS:34547103740

VL - 13

SP - 4046

EP - 4050

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 14

ER -